DrugPatentWatch Database Preview
Indivior Inc Company Profile
What is the competitive landscape for INDIVIOR INC, and what generic alternatives to INDIVIOR INC drugs are available?
There are twelve US patents protecting INDIVIOR INC drugs.
There are one hundred and fifty-four patent family members on INDIVIOR INC drugs in twenty-seven countries.
Summary for Indivior Inc
| International Patents: | 154 |
| US Patents: | 12 |
| Tradenames: | 4 |
| Ingredients: | 3 |
| NDAs: | 5 |
| Patent Litigation for Indivior Inc: | See patent lawsuits for Indivior Inc |
Drugs and US Patents for Indivior Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indivior Inc | SUBOXONE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 022410-001 | Aug 30, 2010 | RX | Yes | No | 8,603,514 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Indivior Inc | SUBOXONE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 022410-002 | Aug 30, 2010 | RX | Yes | No | 9,687,454 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Indivior Inc | SUBOXONE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 022410-004 | Aug 10, 2012 | RX | Yes | Yes | 9,687,454 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 29, 2017 | RX | Yes | No | 9,272,044 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for INDIVIOR INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Sublingual Film | 2 mg/0.5 mg and 8 mg/2 mg | ➤ Subscribe | 2012-10-15 |
| ➤ Subscribe | Sulingual Film | 12 mg/3 mg | ➤ Subscribe | 2014-03-26 |
| ➤ Subscribe | Sublingual Film | 4 mg/1 mg | ➤ Subscribe | 2013-05-14 |
Non-Orange Book US Patents for Indivior Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,910,031 | Process for forming an ingestible thin film with non-self-aggregating uniform heterogeneity | ➤ Try a Free Trial |
| 7,425,292 | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom | ➤ Try a Free Trial |
| 2,016,206,639 | ➤ Try a Free Trial | |
| 9,108,340 | Process for manufacturing a resulting multi-layer pharmaceutical film | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Indivior Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 03030882 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 03030883 | ➤ Try a Free Trial |
| Canada | 2514897 | ➤ Try a Free Trial |
| Denmark | 2332523 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
